Medline.ru - | Табакокурение и эпидемиология хронической обструктивной болезни легких

Reference list

1. Avdeev S.N. Rol legochnoi giperinflyacii v patogeneze hronicheskoi obstryktivnoi bolezni lyogkih. Rol podderjivaushei terapii v ymenshenii legochnoi giperinflyacii//Pylmonologiya, 2004.-t. 14.-№6.-101-110;

2. Andreeva V.M. Differencirovannii ekologo-fiziologicheskii podhod k diagnostike i korrekcii dizadaptacii, otyagoshyonnih tabakokyreniem pri informacionnoi nagryzke v VYZe//Avtoreferat diss. na soiskanie ych. stepeni k. b. n., Ylyanovsk, 2006.-22 str.;

3. Antonov N.S. Klinicheskie primeri primeneniya foradila vo vremya otkaza ot kyreniya/N.S. Antonov, G.M. Saharova//Prilojenie k jyrnaly “Consilium Medicum”, 2005.-t. 7.-№1;

4. Brimkylov N.N. Osobennosti tabachnoi zavisimosti y pacientov s hronicheskoi obstryktivnoi boleznu lyogkih/N.N. Brimkylov, D.V. Vinnikov//Pylmonologiya, 2003.-t. 13.-№3.-20-24;

5. Vostrikova E.A. Kyritelnii statys organizovannogo naseleniya promishlennogo centra/E.A. Vostrikova, A.G. Osipov, L.O. Bagrova i dr. //Pylmonologiya, 2005.-t. 15.-№2.-78-83;

6. Gambaryan M.G. Izychenie vzaimosvyazei faktorov riska hronicheskoi obstryktivnoi bolezni lyogkih i optimizaciya eyo profilaktiki: ypravlenie riskom, svyazannim s kyreniem tabaka. Diss. na soiskanie ychenoi stepeni kand. med. nayk, Moskva, 2002.-197 s.;

7. Gnoevih V.V. Hronicheskaya obstryktivnaya bolezn lyogkih. Izdanie dlya praktikyushih vrachei i issledovatelei: monografiya.-Ylyanovsk: YlGY, 2007.-ISBN 978- 5-88866-276-2.-174 str.;

8. Gnoevih V.V. Razrabotka respiratorno-gazovogo indeksa dlya ekspress-ocenki obosnovannosti naznacheniya lecheniya bolnim hronicheskoi obstryktivnoi boleznu lyogkih/V.V. Gnoevih, M.V. Rydkevich//Obozrenie prikladnoi i promishlennoi matematiki, 2003.-t. 10.-vip. 1.-135-136;

9. Gnoevih V.V. Effektivnost adaptacii respiratornoi sistemi k kyreniu y stydentov medicinskih vyzov pri nikotinassociirovannom riske hronicheskoi obstryktivnoi bolezni lyogkih//Pylmonologiya, 2005.-t.15.-№3.-69-73;

10.Gnoevih V.V. Matematicheskoe modelirovanie rannih nikotinassociirovannih disfynkcii pylmo-kardialnoi sistemi na nachalnih etapah razvitiya HOBL//Pylmonologiya, 2007.-№2.-63-67;

11.Gnoevih V.V. Mediko-socialnie posledstviya tabakokyreniya y bydyshih vrachei s nikotinassociirovannim riskom hronicheskoi obstryktivnoi bolezni lyogkih/V.V. Gnoevih, V.I. Gorbynov, V.A. Semenov i dr. //Problemi ypravleniya zdravoohraneniem, 2006.-№3.-S. 50-56;

12.Gnoevih V.V. Nikotininassociirovannie osobennosti kachestva jizni y bolnih bronhialnoi astmoi molodogo vozrasta/V.V. Gnoevih, V.A. Semenov, E.A. Shalashova//Izvestiya visshih ychebnih zavedenii. Povoljskii region. Seriya «Medicinskie nayki», 2006. - № 1 (22).-81-91;

13.Gnoevih V.V. Gendernie osobennosti adaptacii pylmo-kardialnoi sistemi k tabakokyreniu sredi bydyshih vrachei//Izvestiya visshih ychebnih zavedenii. Povoljskii region. Seriya «Medicinskie nayki», 2007.-№ 1(28).-62-73;

14.Emelyanov A.V. Aktyalnie voprosi lecheniya hronicheskoi obstryktivnoi bolezni lyogkih stabilnogo techeniya//RMJ, 2005.-t.13.-№21.-1386-1393;

15. Zarembo I.A. Vedenie bolnih hronicheskoi obstryktivnoi boleznu lyogkih//RMJ, 2004.-t. 12.-№24.-362-368;

16. Zaridze D.G. Kyrenie - osnovnaya prichina visokoi smertnosti rossiyan/ D.G. Zaridze, R.S. Karpov, S.M. Kiseleva i dr.//Vestnik RAMN, 2002.- №9.-40-45;

17. «Zdorove lyogkih v Evrope»: fakti i cifri. Adaptirovannaya versiya “White Book”/per. A.G. Chychalina, N.S. Antonova, E. Koryaginoi, 2003;

18.Ivchik T.V. Faktori riska hronicheskoi obstryktivnoi bolezni lyogkih/ T.V. Ivchik, A.N. Kokosov, E.D. Yanchina i dr.//Pylmonologiya, 2003.-t. 13.-№3.-6-15;

19. Kalmanova E.N. Issledovanie respiratornoi fynkcii i fynkcionalnii diagnoz v pylmonologii/E.N. Kalmanova, Z.R. Aisanov//RMJ.-2000.-t.8.-№12.-510-514;

20. Komarov F.I. Odishka i ydyshe/ F.I. Komarov, I.G. Danilyak, V.G. Alekseev, A.I. Sinopalnikov//Klinicheskaya medicina, 1996.-№8.-64-67;

21.Kompleksnoe lechenie tabachnoi zavisimosti i profilaktika hronicheskoi obstryktivnoi bolezni lyogkih, vizvannoi kyreniem tabaka. Metodicheskie rekomendacii Ministerstva zdravoohraneniya i socialnogo razvitiya RF №2002/154. M., 2003;

22.Levshin V.F. Problema tabakokyreniya i pyti eyo resheniya. V knige «Kyrenie ili zdorove Rossii? Seriya dokladov po politike v oblasti ohrani zdorovya naseleniya «Zdorove dlya vseh – vsyo dlya zdorovya» pod red. A.K. Dyomina.-M: 1996;

23.Leshenko I.V. Osnovnie polojeniya mejdynarodnih klinicheskih rekomendacii po diagnostike i lecheniu hronicheskoi obstryktivnoi bolezni lyogkih/I.V. Leshenko, N.A. Esaylova//Pylmonologiya, 2005.t.15-№3.-101-111;

24.Nonikov V.E. Hronicheskaya obstryktivnaya bolezn lyogkih (HOBL): diagnostika i lechenie//Consilium Medicum, 2004.-t.6.-№1;

25.Nonikov V.E. Hronicheskaya obstryktivnaya bolezn lyogkih: diagnostika i lechenie//Vrach, 2002.-3.-3-5;

26.Nonikov V.E. Hronicheskaya obstryktivnaya bolezn lyogkih: terapiya pri stabilnom techenii//Consilium Medicum, 2006.-t.8.-№3.-66-70;

27.Oganov R.G. Vliyanie kyreniya na smertnost ot hronicheskih neinfekcionnih zabolevanii po rezyltatam prospektivnogo issledovaniya/G.G. Oganov, A.D. Deev, G.S. Jykovskii//Problemi profilaktiki zabolevanii i ykrepleniya zdorovya, 1998.-№3.-13- 15;

28.Odishka: mehanizmi, ocenka, lechenie. Konsensys. Oficialnii dokyment Amerikanskogo torakalnogo obshestva//Pylmonologiya, 2005.-t. 15.-№2.-9-36;

29.Otraslevoi standart. Protokol vedeniya bolnih. Hronicheskaya obstryktivnaya bolezn lyogkih. OST PVB. M., 2003.-241 s.;

30. Rakita D.D. Vliyanie kyreniya na techenie hronicheskoi obstryktivnoi bolezni lyogkih//Diss. na soiskanie ych. st. kand. med.nayk, Ryazan, 2004.-124 s.;

31. Rydkevich M.V. Stohasticheskaya imitacionnaya model odnogo mehanizma pylmo- kardialnoi sistemi//Avtoreferat diss. na soiskanie ych. stepeni k. f.-m. n., Ylyanovsk, 2005.-15 str.;

32. Saharova G.M. Lechenie tabachnoi zavisimosti/G.M. Saharova, A.G. Chychalin //Pylmonologiya, 2001.-t. 9.-№5.-168-172;

33.Sinopalnikov A.I. Infekcionnoe obostrenie hronicheskoi obstryktivnoi bolezni lyogkih/A.I. Sinopalnikov, A.G. Romanovskih//Atmosfera. Pylmonologiya i allergologiya, 2006.-№3.-15-22;

34. Soglasovannoe zayavlenie Evropeiskogo Respiratornogo obshestva (ERS). Optimalnaya ocenka i lechenie hronicheskoi obstryktivnoi bolezni lyogkih. Spec. pril.// RMJ, 1998.-t.2.-№ 3

35.Tkachenko G.B. O sityacii, svyazannoi s kyreniem tabaka v Rossii//Nijegorod. med. jyrn., 1998.-№1.-7-10;

36.HOBL: rykovodstvo po diagnostike i lecheniu. Prakticheskoe rykovodstvo dlya vrachei. Federalnaya programma, vtoroe izd., M., 2004;

37.Hronicheskie obstryktivnie bolezni lyogkih. Federalnaya programma/ Z.R. Aisanov, A.N. Kokosov, S.I. Ovcharenko i dr. //RMJ, 2001.-t.9.-№1.-9-35;

38.Hronicheskaya obstryktivnaya bolezn lyogkih. Prakticheskoe rykovodstvo dlya vrachei/Pod red. A.G. Chychalina.-M.: OOO «Kolor It Stydio», 2004.- 64s.;

39. Chernyaev A.L. Diagnosticheskie oshibki v pylmonologii//Pylmonologiya, 2005.- t. 15.-№3.-5-10;

40.Chikina S.U. Vnelaboratornaya ocenka odishki i fynkcionalnogo statysa pri bronholegochnoi patologii (obzor literatyri)//Pylmonologiya, 2004.-t. 14.-№5-98-108;

41.Chychalin A.G. Belaya kniga. Pylmonologiya. Rossiya 2003. M., 2003;

42. Chychalin A.G. Bolezni lyogkih kyryashego cheloveka//Terapevticheskii arhiv, 1998.- t. 70.-№3.-5-13;

43.Chychalin A.G. Infekcionnoe obostrenie HOBL: prakticheskie rekomendacii po diagnostike, lecheniu i profilaktike. Posobie dlya vrachei/A.G. Chychalin, A.I. Sinopalnikov, R.S. Kozlov i dr. M., 2005.-37 s.;

44.Chychalin A.G. Klinicheskie rekomendacii po hronicheskoi obstryktivnoi bolezni lyogkih. M., 2001;

45.Chychalin A.G. Odishka: patofiziologicheskie i klinicheskie aspekti// Pylmonologiya, 2004.-t. 14.-№5.-6-16;

46.Chychalin A.G. Prakticheskoe rykovodstvo po lecheniu tabachnoi zavisimosti/ A.G. Chychalin, G.M. Saharova, K.U. Novikov//RMJ, 2001.-t.9.-№21.-904-911;

47.Chychalin A.G. Fynkcionalnii diagnoz y bolnih hronicheskoi obstryktivnoi boleznu lyogkih/A.G. Chychalin, Z.R. Aisanov, E.N. Kalmanova//Hronicheskie obstryktivnie bolezni lyogkih. Pod red. A.G. Chychalina. M: Binom, 1999.-130-144;

48.Shalashova E.A. Diagnostika rannih izmenenii fynkcionalnogo sostoyaniya kardio-respiratornoi sistemi y bolnih bronhialnoi astmoi //Avtoreferat diss. na soiskanie ych. stepeni k. m. n., Ylyanovsk, 2006.-24 str.;

49.Shmelev E.I. Hronicheskaya obstryktivnaya bolezn lyogkih. M., 2003;

50.Shtrub G. Lovyshki, v kotorie mojno ygodit pri lechenii bronhialnoi astmi//Lechashii vrach, 1998.-№4.-4-7;

51.Abbot N.C. Hypnotherapy for smoking cessation/ N.C. Abbot, L.F. Stead, A.R. White et al.//Cochrane Database Syst. Rev., 2000.-2.-CD001008;

52.American Thoracic Society. Dyspnea: mechanisms, assessment, and management: A Consensus Statement. Am. J. Respir. Crit. Care Med., 1999.- 159.-321–40;

53.Anthonisen N.R. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilatator on the rate of decline of FEV1. The Lung Health Study/ N.R. Anthonisen, J.E. Connett, J.P. Kiley et al.//JAMA, 1994.-272.-1497-1505;

54.Anto J.M. Epidemiologe of chronic pulmonary disease/J.M. Anto, J. Sunyer, P. Vermeire et al.//Eur Respir. J., 2001.-17(5).-982-994;

55.Arno P. Tobacco Industry Strategies to Oppose Federal Regulation/P. Arno, A. Brandt, L. Gostin et al.//JAMA, 1996.-Vol. 275.-16.-1258-1262;

56. Bakke P.S. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: A Norwegian Community Study/ P.S. Bakke, R. Hanoa, A. Gulsvik//Am. J. Epidemiol., 1995.-141.-1080-1088;

57. Bakke P.S. Prevalence of obstructive lung disease in a general population: relation of occupational title and exposure to some aitborne agents/ P.S. Bakke, V. Baste, R. Hanoa et al.//Thorax, 1991.-46.-863-870;

58. Balfour D. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders/ D. Balfour, K.O. Fagerstrom//Pharmacology & Therapeutics, 1996.-72.-51-58;

59. Bartal M. COPD and tobacco smoke//Monaldi Arch. Chest Dis., 2005.-Vol.63(4).-213- 25;

60. Bascom R. Differential susceptibility to tobacco smoke: possible mechanisms//Pharmacogenetics, 1991.-1.-102-106;

61. Burchfiel C.M. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function/C.M. Burchfiel, E.B. Marcus, D. Curb et al.//Am. J. Respir. Crit. Care Med., 1995.-151.-1778-1785;

62. Campbell I.A. Overview of doctor intervention//ERS Learning Resources: Smoking cessation, Bucharest, 2004. http:// www.ersnet.org/ ers/lr/browse/ default.aspx?id=1848;

63. Campbell I.A. Smoking and medical education//ERS Learning Resources: Smoking cessation, Bucharest, 2004.-http:// www.ersnet.org/ ers/lr/browse/ default.aspx?id=1848;

64. Cerveri I. Chronic cough and phlegm in young adults/I. Cerveri, S. Accordini, A. Corsico//Eur. Respir. J., 2003.-22.-413-417;

65. Cerveri I. Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults/I. Cerveri, S. Accordini, G. Verlato et al.//Eur Respir J, 2001.- 18.-85-92;

66. Ciobani M. Polyaddictions Part II//ERS Learning Resources: Smoking cessation, Bucharest, 2004.-http:/ /www.ersnet.org/ ers/lr/browse/default.aspx?id=1848

67. Ciobani M. Smoking cessation in patients with respiratory disorders//ERS Learning Resources: Smoking cessation, Bucharest, 2004.- http://www.ersnet.org/ers/lr/browse/default.aspx?id=1848

68. Clark K.D. Cigarette smoke inhalation and lung damage in smoking volunteers/ K.D. Clark, N. Wardrobe-Wong, J.J. Elliott //Eur Respir J, 1998.-12(2).-395-399;

69.Dagli E. The world tobacco epidemic//ERS Learning Resources: Smoking cessation, Bucharest, 2004.-http:// www.ersnet.org/ ers/lr/browse/ default.aspx?id=1848;

70.Dagli E. Women and tobacco.//ERS Learning Resources: Smoking cessation, Bucharest, 2004.-http://www.ersnet.org/ers/lr/browse/default.aspx?id=1848;

71.De Marco R. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages/R. De Marco, S. Accordini, I. Cerveri et al.//Thorax, 2004.-59(2).-120-125;

72.Doll R. The mortality of doctors in relation to their smoking habits/R. Doll, A.B. Hill//BMJ, 1954.-1451-1455;

73.Doll R. Mortality in relation to smoking: 40 years' observations on male British doctors/R. Doll, R. Peto, K. Wheatley et al.//BMJ, 1994.-309.-901-911;

74.Doll R. Mortality in relation to smoking: 50 years' observations on male British doctors/R. Doll, R. Peto, J. Boreham et al.//BMJ, 2004.-328.-1519-1528;

75. Fagerstrom K.O. Addiction to nicotine//ERS Learning Resources: Smoking cessation, Bucharest, 2004..-http:// www.ersnet.org/ ers/lr/browse/ default.aspx?id=1848;

76. Fagerstrom K.O. Nicotine replacement therapy//ERS Learning Resources: Smoking cessation, Bucharest, 2004.-http:// www.ersnet.org/ers/ lr/browse/default.aspx?id=1848;

77. Fagerstrom K. Nicotine addiction and its assessment/ K. Fagerstrom, T.F. Heaterthon, L.T. Kozlowsky //Ear. Nose Throat J., 1991.-69.-763-768;

78. Fletcher C. The natural history of chronic airflow obstruction/C. Fletcher, R. Peto//Br. Med. J., 1977.-1.-1645-1648;

79.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Updated 2006;

80.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Updated 2005 (Based on an April 1998 NHLBI/WHO Workshop)

81.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: updated 2004;

82.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHBLI/WHO Workshop report. Bethesda: National Heart, Lung and Blood Institute: updated 2003 (www.gold.copd.com);

83.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI / WHO Workshop report. Bethesda: National Heart, Lung and Blood Institute: April 2001. NIH Publication №2701/-1-100;

84.Gnoevykh V. Functional effectiveness of respiratory system adaptation to smoking among medical students with COPD hazard/V. Gnoevykh, V. Valzev // Eur. Respir. J., Sept. 2005.-V 26(Suppl. 49).-60s;

85.Gnoevykh V. New markers of early functional disorders in healthy smokers/V. Gnoevykh, A. Butov, M. Rudkevich et al.// Eur. Respir. J., Sept. 2004.-V 24(Suppl. 48).-S249- 250;

86.Gnoevykh V.V. The “gas-respiratory” index and chronic obstructive pulmonary disease// Eur. Respir. J., Sept. 2003.-V 22(Suppl. 45).-276s;

87.Gourlay S. Clonidine for smoking cessation/ S. Gourlay, L. Stead, N. Benowitz //Cochrane Database Syst. Rev., 2004.-3.-CD000058;

88.Haustein K.O. Tobacco or health? Spring, 2003;

89.Hill S.E. Mortality among "never smokers" living with smokers: two cohort studies, 1981-4 and 1996-9/ S.E. Hill, T.A. Blakely, I. Kawachi et al.//BMJ, 2004.-328.-988-989;

90. Janus E.D. Smoking, lung function, and alpha1-antitrypsin deficiency/ E.D. Janus, N.T. Phillips, R.W. Carrell //Lancet, 1985.-1.-152-154;

91.Kauffmann F. Twelve years spirometric changes among Paris area workers/ F. Kauffmann, D. Drouet, J. Lellouch et al.//Int. J. Epidemiol., 1979.-8.-201-212;

92. Kerstens H.A.M. Decline of EFV1 by age and smoking status: facts, figures an fallacies/H.A.M. Kerstens, B. Rijcken, J.P. Schouten et al.//Thorax, 1997.-52.-820-827;

93.Kevin W.G. Markers of inflammation in exhaled breath condensate of young healthy smokers/ W.G. Kevin, M.N. Melinda, A.R. Richard//Chest, 2004.-125.-22-26;

94.Lancaster T. Silver acetate for smoking cessation/T. Lancaster, L.F. Stead//Cochrane Database Syst. Rev., 2000.-2.-CD000191;

95.Lindstrom M. Smoking, respiratory symptoms and diseases/ M. Lindstrom, J. Kotaniemi, E. Jonson et al.//Chest, 2001.-119.-852–861;

96.Management of Chronic Obstructive Pulmonary Disease Eur. Respir. Monograph 38/Edited by Siafakas N.M.//European Respiratory Society J, 2006.-V. 11.-475 pp.;

97.Mannino D.M. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity//Chest, 2002.-5(Suppl):121S-126S;

98.Mannino D.M. The natural history of chronic obstructive pulmonary disease/ D.M. Mannino, G. Watt, D. Hole et al.//Eur. Respir. J., 2006.-27.-627-643;

99.Mihaltan F. From the tobacco plant to cigarettes/F. Mihaltan, I. Munteanu //ERS Learning Resources: Smoking cessation, Bucharest, 2004.- http://www.ersnet.org/ers/lr/browse/default.aspx?id=1848;

100. Nemery B. European legislation and smoking on the workplace//ERS Learning Resources: Smoking cessation, Bucharest, 2004.- http://www.ersnet.org/ers/lr/browse/default.aspx?id=1848;

101. Niewoehner D.E. Pathological changes in the peripheral airways of young cigarette smokers/D.E. Niewoehner, J. Klienerman, D. Rice//N. Engl. J. Med., 1974.-291.-755-758;

102. Osinubi O.Y.O. Tobacco in the workplace/ O.Y.O. Osinubi, J. Slade //Occupational Medicine: State of the Art Reviews, 2002.-17.-137-158;

103. Prescott E. Gender difference in smoking effects of lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study/ E. Prescott, A.M. Bjerg, P.K. Andersen et al.//Ibid, 1997.-10(4).-822-827;

104. Ragout N.A.S. Treatment of tobacco use and dependence//N. Engl. J. Med., 2000.- 346(7).-506-512;

105. Ramírez-Venegas A. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco/A. Ramírez-Venegas, R.H. Sansores, R. Pérez-Padilla//Am. J. Respir. Crit. Care Med., 2006.-Vol.173(4).-393-397;

106. Respiratory Diseases in Women. European Respiratory Monograph 25/Edited by Buist S., Mapp C.E., European Respiratory Society J., 2003.-V. 8.-241 pp.;

107. Rijcken B. Epidemiology of chronic obstructive pulmonary disease. Management of chronic pulmonary disease/B. Rijcken, J. Britton //Eur. Respir. Monograph., 1998.-3(7).-41-73;

108. Royal College of Physicians. Nicotine addiction in Britain. London. Royal College of Physicians, 2000

109. Shiffman S. Nicotine delivery systems: How far has technology come?/S. Shiffman, R. Fant, J. Gitchell et al.//Am. J. of Drug Delivery, 2003.-1.-113-124;

110. Siafakas N.M. Few smokers develop COPD. Why?/ N.M. Siafakas, E.G. Tzortzaki//Respir. Med., 2002.-96.-615-624;

111. Spurzem J.R. Pathogenesis of COPD/J.R. Spurzem, S.I. Rennard //Semin. Respir. Crit. Care Med., 2005.-Vol.26(2).-142-153;

112. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. ATS statement//Amer. J. Respir. Crit. Care Med.-1995.-152.-77–120;

113. Standards for the diagnosis and care of patients with COPD: a summary of the ATS/ERS position paper/B.R. Celli, W. Mac Nee and committee members//Eur. Respir. J., 2004.-23.-932-946;

114. Stover D.E. Women, smoking and lung cancer//Chest, 1998.-113.-1-2;

115. Sutherland E.R. Management of chronic obstructive pulmonary disease/E.R. Sutherland, R.M. Cherniack//N. Engl. J. Med., 2004.-350.-2689-2697;

116. Sweeny C.T. Combination nicotine replacement therapy for smoking cessation: Rationale, efficacy and tolerability/ C.T. Sweeny, R.V. Fant, K.O. Fagerstrom et al.//CNS Drugs, 2001.-15.-453-467;

117. The ASPECT Consortium. Tobacco or Health in the European Union. Past, present and future. Luxembourg. Office for Official Publications of the European Communities, 2004.- 290 pp.;

118. The Tobacco Atlas. WHO, 2002;

119. Tonnesen Ph. Others interventions in smoking//ERS Learning Resources: Smoking cessation, Bucharest, 2004.-http:// www.ersnet.org/ ers/lr/browse/ default.aspx?id=1848;

120. Trofor A. ABC of health disorders related to tobacco use and passive smoking//ERS Learning Resources: Smoking cessation, Bucharest, 2004.- http://www.ersnet.org/ers/lr/browse/default.aspx?id=1848;

121. Trofor A. Health disorders related to tobacco use and passive smoking//ERS Learning Resources: Smoking cessation, Bucharest, 2004.- http://www.ersnet.org/ers/lr/browse/default.aspx?id=1848;

122. Trofor A. Polyaddictions Part I//ERS Learning Resources: Smoking cessation, Bucharest, 2004. - http : // www.ersnet.org/ers/lr/browse/default.aspx?id=1848;

123. Tzanakis N./ N. Tzanakis, T. Papadopouli, M. Koziraky et al.//Eur. Resp. J., 1996.- Vol. 9, Suppl.-261;

124. Urrutia I. Smoking habit, respiratory symptoms and lung function in young adults/I. Urrutia, A. Capelastegui, J.M. Quintana, et al. and the Spanish Group of the European Community Respiratory Health Survey//The Eur. J. of Public Health, 2005.-15(2).-160-165;

125. Van der Meer R.M. Smoking cessation for COPD/R.M. Van der Meer, E.J. Wagena, R.W. Ostelo//The Cochrane Library.-Issue 2.-Oxford, 2003;

126. Van der Vaart H. Acute effects of cigarette smoking on inflammation in healthy intermittent smokers/H. Van der Vaart, D.S. Postma, W. Timens et al.//Respir. Res., 2005.-Vol. 6.-22;

127. Wennike P. Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up/ P. Wennike, T. Danielsson, B. Landfeldt et al.//Addiction, 2003.-98.-1395-1402;

128. White A.R. Acupuncture for smoking cessation/ A.R. White, H. Rampes, E. Ernst//Cochrane Database Syst. Rev., 2002.-2.-CD000009;

129. World Health Organization - Guidelines for controlling and monitoring the tobacco epidemic. Geneva, WHO, 1998;

130. Zock J.P. Occupation, chronic bronchitis and lung function in young adults. An international study/J.P. Zock, J. Sunyer, M. Kogevinas//Am. J. Respir. Crit. Care Med., 2001.- 163(7).-572–577